Clinical Trial Update: Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients

View source ↗

Summary

This completed clinical trial evaluated the kinetics of the YKL-40 protein in the serum of cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Cystic Fibrosis | Status: COMPLETED